Bioinformatics & Systems Biology
Global

Bioinformatics & Systems Biology Experts

Anna r. giuliano

Researcher
Deparment of Cancer Epidemiology
Moffitt Cancer Center
United States of America

Anna r. giuliano

Biography

Dr. Anna R. Giuliano is affiliated to Deparment of Cancer Epidemiology, Moffitt Cancer Center. Dr. Anna R. Giuliano is currently providing services as Researcher. Dr. Anna R. Giuliano has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Anna R. Giuliano contributions have acclaimed recognition from honourable subject experts around the world. Dr. Anna R. Giuliano is actively associated with different societies and academies. Dr. Anna R. Giuliano academic career is decorated with several reputed awards and funding. Dr. Anna R. Giuliano research interests include Her career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer in women, and has evolved over the past several decades to encompass HPV and penile, anal, and oral cancers in men, as well as other infectious diseases and their causal relationships with various cancers. .

Research Interest

Her career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer in women, and has evolved over the past several decades to encompass HPV and penile, anal, and oral cancers in men, as well as other infectious diseases and their causal relationships with various cancers. 

Publications

  • Nunes EM, López RV, Sudenga SL, Gheit T, Tommasino M, Baggio ML, Ferreira S, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR. Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study. Virology. 2017 Oct 1;510:55-9.

  • Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial. The Lancet. 2017 Sep 5.

  • Flores-Díaz E, Sereday KA, Ferreira S, Sirak B, Sobrinho JS, Baggio ML, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL. HPV-11 variability, persistence and progression to genital warts in men: the HIM study. Journal of General Virology. 2017 Aug 15.

Global Experts from United States of America

Global Experts in Subject

Share This Profile